Table of Content

Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary

Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints

Part 5. Global market for interventional oncology devices by product
5.1 Embolization devices
5.1.1 Market size and forecast
5.2 Ablation devices
5.2.1 Market size and forecast
5.3 Others
5.3.1 Market size and forecast

Part 6. Global market for interventional oncology devices by cancer type
6.1 Liver cancer
6.1.1 Market size and forecast
6.2 Lung cancer
6.2.1 Market size and forecast
6.3 Kidney cancer
6.3.1 Market size and forecast
6.4 Breast cancer
6.4.1 Market size and forecast
6.5 Prostate cancer
6.5.1 Market size and forecast
6.6 Bone metastasis
6.6.1 Market size and forecast

Part 7. Global market for interventional oncology devices by end use
7.1 Hospitals & clinics
7.1.1 Market size and forecast
7.2 Ambulatory care centers
7.2.1 Market size and forecast

Part 8. Global market for interventional oncology devices by region
8.1 Asia Pacific
8.1.1 Market size and forecast
8.2 Europe
8.2.1 Market size and forecast
8.3 North America
8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
8.4.1 Market size and forecast

Part 9. Key competitor profiles
9.1 AngioDynamics, Inc.
9.2 Becton, Dickinson and Company
9.3 Boston Scientific Corporation
9.4 BTG Limited
9.5 Cook Group Incorporated
9.6 HealthTronics, Inc.
9.7 IceCure Medical Ltd
9.8 Johnson & Johnson
9.9 Medtronic plc
9.10 Sirtex Medical Limited
9.11 SonaCare Medical, LLC
9.12 Terumo Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER
ABOUT GEN CONSULTING COMPANY